Sonoma pharmaceuticals reports first quarter 2022 financial results

Woodstock, ga.--(business wire)--sonoma pharmaceuticals, inc. (nasdaq: snoa), a global healthcare leader developing and producing stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound care, eye, oral and, nasal care, disinfectant use and dermatological conditions today announced financial results for its first fiscal quarter ended june 30, 2021. “this quarter marks the transition from having a dedicated dermatology sales force for our prescription produc
SNOA Ratings Summary
SNOA Quant Ranking